Provided by Tiger Trade Technology Pte. Ltd.

OCUMENSION-B

5.360
-0.155-2.81%
Volume:520.94K
Turnover:2.72M
Market Cap:4.37B
PE:-22.93
High:5.505
Open:5.300
Low:4.975
Close:5.515
52wk High:9.850
52wk Low:4.040
Shares:815.00M
HK Float Shares:815.00M
Volume Ratio:2.16
T/O Rate:0.06%
Dividend:- -
Dividend Rate:- -
EPS(LYR):-0.234
ROE:-3.45%
ROA:-1.93%
PB:1.03
PE(LYR):-22.93
PS:4.00

Loading ...

Legal Claim Against Xiangxue Pharmaceutical Filed, Additional Eligible Investors Invited

Deep News
·
Jun 04

New Legal Actions Filed for Shareholder Compensation Claims Against Two Listed Companies

Deep News
·
Jun 04

HighLight Pharmaceutical-B's Hong Kong IPO Application Lapses

Stock News
·
Jun 04

Key Figure Departs ByteDance's AI Research Unit, Eyeing Venture in AI Drug Discovery

Deep News
·
Jun 03

Fulcrum Therapeutics Halts Development of Sickle Cell Drug Due to Safety Concerns, Shares Plunge Over 50% as Company Explores Sale

Deep News
·
Jun 02

ASCLETIS-B Executes Share Buyback, Spending HK$2.06 Million on 200,000 Shares

Stock News
·
Jun 02

Morgan Stanley Adjusts Target Price for SBP GROUP, Maintains Positive Outlook

Stock News
·
Jun 01

Ark Jianke Shares Surge Over 15% Intraday Following Strategic AI Health Partnership with Tengrui Pharmaceutical

Stock News
·
Jun 01

Replimune Shares Soar 72% on Plan for Third FDA Submission of Melanoma Drug

Deep News
·
May 29

Pharmaceutical Firm Lupeng Biotech Files for Hong Kong IPO Again

Stock News
·
May 28

Ocumension Therapeutics Enrolls First Patient in Presbyopia Drug Trial

MT Newswires Live
·
May 28

Chongqing Genrix Biopharmaceutical Inks Up to RMB 1.82 Billion Licensing Deal for GR1803 with Pharma Partner

Stock News
·
May 28

OCUMENSION-B Achieves First Patient Enrollment in Phase III Trial for OT-802

Stock News
·
May 28

Ocumension reports first patient enrolled in Phase III China trial for presbyopia candidate OT-802

Bulletin Express
·
May 28

Ocumension enrolls first patient in China Phase III trial of presbyopia drug OT-802

Reuters
·
May 28

Harmony Biosciences Management to Present at Upcoming Investor Conferences

Deep News
·
May 27

Pharmaceutical Sector Shows Resilience at Low Levels, Huabao Pharma ETF (562050) Rises Against Market Trend in Afternoon Session! Leading Stock Hengrui Pharma Surges 4%, Traditional Chinese Medicine Leaders All in the Green

Deep News
·
May 27

Mingyu Pharmaceutical's Hong Kong IPO Application Lapses After Six Months

Stock News
·
May 26

Guojin Securities Initiates Coverage on Insilico with a "Buy" Rating, Anticipating Key Validation Milestone in AI Drug Discovery

Stock News
·
May 25

CSPC PHARMA Earns Spot on Prestigious 2026 Global Pharmaceutical Brand Value Ranking

Deep News
·
May 22